US 8741866
Compositions and methods for inhibiting expression of transthyretin
granted A61KA61K31/713A61K9/0019
Quick answer
US patent 8741866 (Compositions and methods for inhibiting expression of transthyretin) held by Alnylam Pharmaceuticals, Inc. expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/713, A61K9/0019, A61P, A61P1/00